Signs of diastolic dysfunction are graded by serum testosterone levels in aging C57BL/6 male mice

Mech Ageing Dev. 2021 Sep:198:111523. doi: 10.1016/j.mad.2021.111523. Epub 2021 Jun 21.

Abstract

We investigated whether maladaptive, age-associated changes in heart structure and function were linked to circulating testosterone levels. Male C57BL/6 mice had a gonadectomy (GDX) or sham surgery at 4 weeks and effects of GDX on the heart were examined with echocardiography. Serum testosterone was measured with ELISA. Left ventricular (LV) mass increased with age but was smaller in GDX mice than sham at 18 months (144.0 ± 8.7 vs 118.2 ± 11.9 mg; p = 0.009). The isovolumic relaxation time (IVRT) declined with age but was prolonged in GDX mice at 18 months (10.5 ± 0.8 vs 12.5 ± 0.5 msec, p = 0.008). Ejection fraction did not change with age or GDX, but E/A ratios were lower in GDX mice than controls at 18 months (1.6 ± 0.2 vs 1.3 ± 0.1, p = 0.021). When links between serum testosterone and cardiac parameters were examined longitudinally in 18-24-month-old mice, LV mass declined with decreasing testosterone (β = 37.70, p = 0.016), however IVRT increased as testosterone decreased (β=-2.69, p = 0.036). Since longer IVRT and lower E/A ratios are signs of diastolic dysfunction, low circulating testosterone may promote or exacerbate diastolic dysfunction in older males. These findings suggest that lower testosterone directly modifies heart structure and function to promote maladaptive remodeling and diastolic dysfunction in the aging heart.

Keywords: Aging; Cardiac remodelling; Diastolic dysfunction; Testosterone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / physiology*
  • Animals
  • Correlation of Data
  • Echocardiography / methods
  • Heart Ventricles* / diagnostic imaging
  • Heart Ventricles* / pathology
  • Heart Ventricles* / physiopathology
  • Mice
  • Mice, Inbred C57BL
  • Organ Size
  • Stroke Volume*
  • Testosterone / blood*
  • Ventricular Remodeling*

Substances

  • Testosterone

Grants and funding